|
Market Closed -
NYSE
16:00:02 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 96.54 USD | -0.59% |
|
-0.05% | +0.50% |
| Market Cap | 119B 106B 97.93B 88.73B 166B 11,287B 169B 1,168B 469B 5,937B 446B 437B 18,725B | P/E 2027 * |
20.9x | P/E 2028 * | 19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 140B 125B 115B 104B 195B 13,290B 199B 1,375B 552B 6,991B 525B 514B 22,047B | EV / Sales 2027 * |
3.59x | EV / Sales 2028 * | 3.42x |
| Free-Float |
99.65% | Yield 2027 * |
2.92% | Yield 2028 * | 3.12% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| MDT | Delayed | |
CBOE
| MDT | Real-time | |
Tradegate
| 2M6 | Real-time | |
Xetra
| 2M6 | Delayed | |
Deutsche Boerse AG
| 2M6 | Delayed | |
Boerse Muenchen
| 2M6 | Real-time | |
Börse Stuttgart
| 2M6 | Delayed | |
London S.E.
| 0Y6X | Delayed | |
Mexican S.E.
| MDT N | End-of-day quote | |
Borsa Italiana
| 1MDT | End-of-day quote | |
Swiss Exchange
| MDT | Delayed | |
Wiener Boerse
| MDT | End-of-day quote | |
Bulgaria S.E.
| 2M6 | End-of-day quote | |
Swiss Exchange
| MDT | Delayed |
Last Transcript: Medtronic plc
| 1 day | -1.40% | ||
| 1 week | -0.05% | ||
| Current month | +11.88% | ||
| 1 month | +10.85% | ||
| 3 months | +10.28% | ||
| 6 months | +21.63% | ||
| Current year | +0.50% |
| 1 week | 93.04 | 98.09 | |
| 1 month | 85.22 | 98.09 | |
| Current year | 73.31 | 105.5 | |
| 1 year | 73.31 | 106.33 | |
| 3 years | 69.32 | 106.33 | |
| 5 years | 68.84 | 124.63 | |
| 10 years | 68.84 | 135.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 56 | 2020-04-26 |
Michael Marinaro
PSD | President | - | 2026-10-13 |
Thierry Pieton
DFI | Director of Finance/CFO | 56 | 2025-03-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Arnold
BRD | Director/Board Member | 66 | 2015-01-25 |
Scott Donnelly
BRD | Director/Board Member | 64 | 2012-12-31 |
Randall Hogan
BRD | Director/Board Member | 70 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Sell | EVP, Pres MedSurg and Americas | -10,420 | 0.0008% | ||
| 10/15/26 | Sell | Chief Executive Officer | -50,000 | 0.0039% | ||
| 9/16/26 | Sell | Executive/Senior Manager | -1,483 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.59% | -0.05% | +5.24% | +39.05% | 119B | ||
| +1.56% | +3.60% | -14.65% | +14.38% | 181B | ||
| -6.38% | -4.96% | -21.03% | +11.44% | 120B | ||
| +3.42% | +4.04% | -42.10% | +9.69% | 91.44B | ||
| +0.09% | -2.26% | -0.70% | +76.32% | 63.07B | ||
| -0.46% | -0.64% | +9.87% | +80.82% | 55.8B | ||
| -0.23% | -1.27% | +9.01% | -21.35% | 54.03B | ||
| -4.30% | -2.74% | -12.18% | +40.84% | 45.38B | ||
| +0.58% | +2.18% | -0.54% | -6.40% | 34.37B | ||
| +2.95% | +5.07% | +20.70% | -7.84% | 30.16B | ||
| Average | -0.41% | +0.64% | -4.64% | +23.69% | 79.36B | |
| Weighted average by Cap. | -0.55% | +0.81% | -9.26% | +24.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 38.97B 34.9B 32.1B 29.09B 54.38B 3,700B 55.39B 383B 154B 1,946B 146B 143B 6,139B | 40.4B 36.18B 33.28B 30.16B 56.37B 3,836B 57.42B 397B 159B 2,018B 152B 148B 6,363B |
| Net income | 6.04B 5.41B 4.98B 4.51B 8.43B 574B 8.59B 59.35B 23.82B 302B 22.67B 22.19B 952B | 6.51B 5.83B 5.36B 4.86B 9.08B 618B 9.25B 63.91B 25.66B 325B 24.42B 23.9B 1,025B |
| Net Debt | 21.09B 18.89B 17.37B 15.74B 29.43B 2,003B 29.98B 207B 83.17B 1,053B 79.15B 77.47B 3,322B | 19.18B 17.18B 15.8B 14.32B 26.77B 1,822B 27.27B 188B 75.65B 958B 71.99B 70.46B 3,022B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | US$96.54 | -0.59% | 8,680,755 |
| 26-10-29 | US$97.11 | +2.46% | 9,375,742 |
| 26-10-28 | US$94.78 | +0.88% | 9,579,104 |
| 26-10-27 | US$93.95 | -0.89% | 5,454,325 |
| 26-10-26 | US$94.79 | -0.65% | 8,464,533 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDT Stock
Select your edition
All financial news and data tailored to specific country editions

















